BioCentury
ARTICLE | Company News

Eli Lilly's Xigris gets September panel date

July 23, 2001 7:00 AM UTC

The FDA's Anti-Infective Drugs Advisory Committee will review on Sept. 12 LLY's Xigris drotrecogin alfa (formerly Zovant) to treat severe sepsis. In June, the agency extended to Oct. 27 from July 27 i...